Replimune Group, Inc. - Common Stock
(NQ:
REPL
)
3.335
+0.530 (+18.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Replimune Group, Inc. - Common Stock
< Previous
1
2
3
Next >
Which stocks are experiencing notable movement on Wednesday?
July 23, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via
Chartmill
This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
July 23, 2025
Via
Benzinga
From Shriram Properties, Havells To Vesuvius: SEBI RA Sees 15% To 30% Upside In These Six Stocks
July 22, 2025
Via
Stocktwits
Which stocks are experiencing notable movement on Tuesday?
July 22, 2025
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
July 22, 2025
The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 22, 2025
Via
Benzinga
Nasdaq Falls Over 100 Points; Coca-Cola Posts Upbeat Earnings
July 22, 2025
Via
Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
July 22, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Gapping stocks in Tuesday's session
July 22, 2025
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
US Stocks Mixed; General Motors Shares Fall After Q2 Results
July 22, 2025
Via
Benzinga
FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks
July 22, 2025
Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.
Via
Benzinga
Which stocks are moving before the opening bell on Tuesday?
July 22, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 22, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 12, 2025
Via
Benzinga
Earnings Scheduled For May 22, 2025
May 22, 2025
Via
Benzinga
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
April 21, 2025
Via
Benzinga
Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
February 10, 2025
Via
Benzinga
Nasdaq Jumps 100 Points; Charles Schwab Profit Beats Estimates
January 21, 2025
Via
Benzinga
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday
January 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 22, 2024
Via
Benzinga
S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
November 22, 2024
Via
Benzinga
Topics
Stocks
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views
November 22, 2024
Via
Benzinga
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
November 22, 2024
Via
Benzinga
Dow Jumps 300 Points; Gap Posts Upbeat Earnings
November 22, 2024
Via
Benzinga
Topics
Stocks
REPL Stock Earnings: Replimune Group Beats EPS for Q1 2025
August 08, 2024
REPL stock results show that Replimune Group beat analyst estimates for earnings per share the first quarter of 2025.
Via
InvestorPlace
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
June 07, 2024
Via
Benzinga
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
June 06, 2024
Via
Benzinga
Topics
Stocks
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.